tiprankstipranks
Eiger Biopharmaceuticals (DE:72C1)
FRANKFURT:72C1

Eiger Biopharmaceuticals (72C1) Ownership - Who Owns Eiger Biopharmaceuticals?

1 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 02, 2023
Richard Kayne
>10% Owner
Bought$71434
Nov 02, 2023
Kawas Leen
>10% Owner
Bought$6326
Mar 21, 2023
Mayer Eldon C. Iii
Ex Vp & Chief Commerc. Officer
Sold$4703
Jan 25, 2023Bought$71500

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,843,170Insider17,570,791
43,125Insider266,513
2,895Insider17,891
62,500Insider386,250
1,432Insider8,850
1,024Insider6,328
3,125Insider19,313
169Insider1,044
1,587Insider9,808
1,785,190Institution11,032,474

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,930Institution30,467
58,377Institution360,770
69,890Institution431,920
379Institution2,342
186Institution1,149
528Institution3,263
6,925Institution42,797
5,600Institution34,608
384,555Institution2,376,550
129,275Institution798,920

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Eiger Biopharmaceuticals (DE:72C1)?
Currently, no data Available
What percentage of Eiger Biopharmaceuticals (DE:72C1) stock is held by institutional investors?
Currently, no data Available
What percentage of Eiger Biopharmaceuticals (DE:72C1) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Eiger Biopharmaceuticals (DE:72C1)?
Ecor1 Capital, Llc owns the most shares of Eiger Biopharmaceuticals (DE:72C1).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis